A detailed history of Bruce G. Allen Investments, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Bruce G. Allen Investments, LLC holds 30 shares of BMRN stock, worth $1,952. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30
Previous 39 23.08%
Holding current value
$1,952
Previous $3.21 Million 34.32%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$69.02 - $93.84 $621 - $844
-9 Reduced 23.08%
30 $2.11 Million
Q2 2024

Jul 12, 2024

BUY
$74.43 - $92.22 $1,711 - $2,121
23 Added 143.75%
39 $3.21 Million
Q4 2023

Jan 10, 2024

BUY
$76.22 - $98.51 $1,219 - $1,576
16 New
16 $1.54 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Bruce G. Allen Investments, LLC Portfolio

Follow Bruce G. Allen Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bruce G. Allen Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bruce G. Allen Investments, LLC with notifications on news.